Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
long intergenic non-protein coding RNA 2829 (LINC02829) is a member of the long intergenic non-coding RNA family, which comprises RNA molecules transcribed from genomic regions between protein-coding genes but not translated into proteins. LINC02829 is located on chromosome 6 at cytogenetic band 6p22 and is annotated in public databases including Ensembl, HGNC, GeneCards, and Monarch Initiative as a human lincRNA. Like other lincRNAs, LINC02829 may participate in the regulation of gene expression through epigenetic and chromatin-related mechanisms, though its precise biological function, expression profile, and disease relevance remain incompletely characterized. There is no data directly associating LINC02829 with a specific disorder, nor is it used as a clinical biomarker or therapeutic target at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on long intergenic non-protein coding RNA 2829 (LINC02829).